Today's Morning Movers and Top Ratings: NVDA, META, COIN, MMM and More

$Pfizer(PFE.US)$ stock increased by 0.1% as the pharmaceutical giant sold a roughly $3.9 billion stake in the UK-based consumer healthcare company, Haleon, reducing its ownership to 22.6%.

$Spire Global(SPIR.US)$ stock jumped 17% following the announcement of a collaboration with Nvidia to leverage AI for enhanced weather prediction.

$Unilever(UL.US)$ American Depositary Receipts (ADRs) climbed 2.7% after the company announced plans to separate its ice cream business, including brands like Magnum and Ben & Jerry's, and initiate a cost-saving program that includes cutting 7,500 jobs.

$International Flavors & Fragrances(IFF.US)$ stock went up by 0.5% after the company disclosed its intentions to sell its pharmaceutical solutions segment to Roquette, a French producer of plant-based ingredients, in a deal worth $2.85 billion, aiming to concentrate on higher-margin businesses.

$Fusion Pharmaceuticals(FUSN.US)$ stock surged by 99% on news that AstraZeneca (NASDAQ:AZN) would acquire the clinical-stage biopharmaceutical firm for approximately $2 billion in cash.

$XPeng(XPEV.US)$ stock appreciated by 3.2% following the release of quarterly earnings that surpassed expectations, despite signalling a challenging road ahead.

$NVIDIA(NVDA.US)$ stock dropped 1.8%, retracing some of the significant gains made earlier this year after introducing its latest AI chips at its annual developer conference.

$Coinbase(COIN.US)$ stock plummeted 5.2% as the cryptocurrency exchange platform was hit by the sharp downturn in Bitcoin value, the leading digital currency.

$Meta Platforms(META.US)$ saw its stock decrease by 0.8% after the technology conglomerate proposed to lower a monthly subscription fee for Facebook and Instagram amidst regulatory discussions.